CIK 0001651944
DMTK DermTech, Inc.
Insider trading from SEC Form 4. Last filing Jun 12, 2024.
In brief
DermTech, Inc. (DMTK) has 45 SEC Form 4 filings on file from 7 insiders, the latest filed on Jun 12, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
28 open-market trades have been scored at DMTK. The newest: Ramin Akhavan (General Counsel) sold $5,765 of stock on Dec 7, 2023, filed Dec 11, 2023, scored 30 (weak). The largest of the 28 shown: Rtw Investments, LP (10% owner) sold $177k on Nov 4, 2022, scored 24 (weak). 3 insiders sold within 14 days of each other around Dec 7, 2023.
2 Form 144 notices of planned sales are on file, the latest filed Aug 11, 2023.
Last 90 days
Signals
Open-market buys and sells at DermTech, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Ramin Akhavan General Counsel sell | $5,765 3,768 shares | -3% | - | |
| 35Weak | Claudia Ibarra Chief Operating Officer sell | $10k 6,849 shares | -3% | - | |
| 37Weak | Kevin M Sun Chief Financial Officer sell | $8,266 5,426 shares | -2% | - | |
| 30Weak | Ramin Akhavan General Counsel sell | $8,745 4,531 shares | -3% | - | |
| 35Weak | Claudia Ibarra Chief Operating Officer sell | $15k 7,700 shares | -4% | - | |
| 37Weak | Kevin M Sun Chief Financial Officer sell | $19k 9,616 shares | -3% | - | |
| 35Weak | Claudia Ibarra Chief Operating Officer sell | $918 322 shares | -0% | - | |
| 37Weak | Kevin M Sun Chief Financial Officer sell | $1,245 437 shares | -0% | - | |
| 30Weak | Todd Michael Wood Chief Commercial Officer sell | $998 350 shares | -0% | - | |
| 30Weak | Ramin Akhavan General Counsel sell | $9,553 3,776 shares | -2% | - | |
| 35Weak | Claudia Ibarra Chief Operating Officer sell | $16k 6,287 shares | -3% | - | |
| 37Weak | Kevin M Sun Chief Financial Officer sell | $20k 7,816 shares | -3% | - | |
| 30Weak | Todd Michael Wood Chief Commercial Officer sell | $13k 4,992 shares | -2% | - | |
| 40Moderate | John Dobak Chief Executive Officer sell | $5,082 1,559 shares | -0% | - | |
| 35Weak | Claudia Ibarra Chief Operating Officer sell | $1,232 378 shares | -0% | - | |
| 37Weak | Kevin M Sun Chief Financial Officer sell | $1,676 514 shares | -0% | - | |
| 30Weak | Todd Michael Wood Chief Commercial Officer sell | $1,343 412 shares | -0% | - | |
| 40Moderate | John Dobak Chief Executive Officer sell | $5,082 1,559 shares | -0% | - | |
| 35Weak | Ramin Akhavan General Counsel sell | $27k 6,751 shares | -7% | - | |
| 41Moderate | Claudia Ibarra Chief Operating Officer sell | $39k 9,616 shares | -6% | - | |
| 43Moderate | Kevin M Sun Chief Financial Officer sell | $47k 11,707 shares | -5% | - | |
| 36Weak | Todd Michael Wood Chief Commercial Officer sell | $35k 8,713 shares | -4% | - | |
| 50Moderate | John Dobak Chief Executive Officer sell | $97k 23,955 shares | -4% | - | |
| 23Weak | Todd Michael Wood Chief Commercial Officer sell | $790 356 shares | -0% | - | |
| 28Weak | Claudia Ibarra Chief Operating Officer sell | $728 328 shares | -0% | - | |
| 28Weak | Claudia Ibarra Chief Operating Officer sell | $6,125 2,633 shares | -2% | - | |
| 23Weak | Todd Michael Wood Chief Commercial Officer sell | $1,491 633 shares | -0% | - | |
| 24Weak | Rtw Investments, LP owner sell | $177k 100,000 shares | -3% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 11, 2023 | Tellado Monica Director | 35,099 0.10% of outstanding | $92k | Aug 11, 2023 | none |
| Jul 13, 2023 | Dobak John Officer | 20,000 0.07% of outstanding | $70k | Jul 13, 2023 | $38k |
Transactions
The newest 50 of 93 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -445 | $0.34 | $151 | 269,216 | Jun 12, 2024 |
| Jun 5, 2024 | Ramin Akhavan General Counsel | FTax withholding Common Stock | -1,757 | $0.31 | $545 | 130,413 | Jun 7, 2024 |
| Jun 5, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -179 | $0.31 | $55 | 274,427 | Jun 7, 2024 |
| Jun 5, 2024 | Ramin Akhavan General Counsel | FTax withholding Common Stock | -1,988 | $0.31 | $616 | 128,425 | Jun 7, 2024 |
| Jun 5, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -2,236 | $0.31 | $693 | 272,191 | Jun 7, 2024 |
| Jun 5, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -2,530 | $0.31 | $784 | 269,661 | Jun 7, 2024 |
| Mar 10, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -445 | $0.70 | $312 | 274,606 | Mar 12, 2024 |
| Mar 5, 2024 | Ramin Akhavan General Counsel | FTax withholding Common Stock | -1,758 | $0.88 | $1,547 | 134,159 | Mar 7, 2024 |
| Mar 5, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -180 | $0.88 | $158 | 277,319 | Mar 7, 2024 |
| Mar 5, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -2,237 | $0.88 | $1,969 | 275,082 | Mar 7, 2024 |
| Mar 5, 2024 | Ramin Akhavan General Counsel | FTax withholding Common Stock | -1,989 | $0.88 | $1,750 | 132,170 | Mar 7, 2024 |
| Mar 5, 2024 | Kevin M Sun Chief Financial Officer | FTax withholding Common Stock | -2,531 | $0.88 | $2,227 | 272,551 | Mar 7, 2024 |
| Jan 5, 2024 | Ramin Akhavan General Counsel | FTax withholding Common Stock | -3,202 | $1.50 | $4,803 | 135,917 | Jan 9, 2024 |
| Dec 7, 2023 | Ramin Akhavan General Counsel | SOpen-market sale Common Stock | -1,768 | $1.53 | $2,705 | 141,119 | Dec 11, 2023 |
| Dec 7, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -143 | $1.53 | $219 | 200,253 | Dec 11, 2023 |
| Dec 7, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -188 | $1.53 | $288 | 282,737 | Dec 11, 2023 |
| Dec 7, 2023 | Ramin Akhavan General Counsel | SOpen-market sale Common Stock | -2,000 | $1.53 | $3,060 | 139,119 | Dec 11, 2023 |
| Dec 7, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -1,768 | $1.53 | $2,705 | 198,485 | Dec 11, 2023 |
| Dec 7, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -2,248 | $1.53 | $3,439 | 280,489 | Dec 11, 2023 |
| Dec 7, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -2,000 | $1.53 | $3,060 | 196,485 | Dec 11, 2023 |
| Dec 7, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -2,543 | $1.53 | $3,891 | 277,946 | Dec 11, 2023 |
| Dec 8, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -2,607 | $1.41 | $3,676 | 193,878 | Dec 11, 2023 |
| Dec 11, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -447 | $1.45 | $648 | 277,499 | Dec 11, 2023 |
| Dec 11, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -331 | $1.45 | $480 | 193,547 | Dec 11, 2023 |
| Sep 20, 2023 | Mark Bryan Aguillard Chief Commercial Officer | AGrant or award Common Stock | +90,000 | $0.00 | $0 | 90,000 | Sep 22, 2023 |
| Sep 20, 2023 | Mark Bryan Aguillard Chief Commercial Officer | AGrant or award Stock Option (right to buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Sep 22, 2023 |
| Sep 8, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -223 | $1.93 | $430 | 292,318 | Sep 12, 2023 |
| Sep 8, 2023 | Ramin Akhavan General Counsel | SOpen-market sale Common Stock | -2,126 | $1.93 | $4,103 | 145,292 | Sep 12, 2023 |
| Sep 8, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -168 | $1.93 | $324 | 207,928 | Sep 12, 2023 |
| Sep 8, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -2,126 | $1.93 | $4,103 | 205,802 | Sep 12, 2023 |
| Sep 8, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -2,703 | $1.93 | $5,217 | 289,615 | Sep 12, 2023 |
| Sep 8, 2023 | Ramin Akhavan General Counsel | SOpen-market sale Common Stock | -2,405 | $1.93 | $4,642 | 142,887 | Sep 12, 2023 |
| Sep 8, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -2,405 | $1.93 | $4,642 | 203,397 | Sep 12, 2023 |
| Sep 8, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -3,058 | $1.93 | $5,902 | 286,557 | Sep 12, 2023 |
| Sep 8, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -2,679 | $1.93 | $5,170 | 200,718 | Sep 12, 2023 |
| Sep 8, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -3,196 | $1.93 | $6,168 | 283,361 | Sep 12, 2023 |
| Sep 11, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -322 | $1.89 | $609 | 200,396 | Sep 12, 2023 |
| Sep 11, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -436 | $1.89 | $824 | 282,925 | Sep 12, 2023 |
| Jun 12, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -322 | $2.85 | $918 | 208,096 | Jun 14, 2023 |
| Jun 12, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -437 | $2.85 | $1,245 | 290,041 | Jun 14, 2023 |
| Jun 12, 2023 | Todd Michael Wood Chief Commercial Officer | SOpen-market sale Common Stock | -350 | $2.85 | $998 | 284,757 | Jun 14, 2023 |
| Jun 7, 2023 | Ramin Akhavan General Counsel | SOpen-market sale Common Stock | -1,772 | $2.53 | $4,483 | 149,422 | Jun 9, 2023 |
| Jun 7, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -140 | $2.53 | $354 | 214,565 | Jun 9, 2023 |
| Jun 7, 2023 | Todd Michael Wood Chief Commercial Officer | SOpen-market sale Common Stock | -189 | $2.53 | $478 | 289,910 | Jun 9, 2023 |
| Jun 7, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -185 | $2.53 | $468 | 298,109 | Jun 9, 2023 |
| Jun 7, 2023 | Ramin Akhavan General Counsel | SOpen-market sale Common Stock | -2,004 | $2.53 | $5,070 | 147,418 | Jun 9, 2023 |
| Jun 7, 2023 | Claudia Ibarra Chief Operating Officer | SOpen-market sale Common Stock | -1,772 | $2.53 | $4,483 | 212,793 | Jun 9, 2023 |
| Jun 7, 2023 | Todd Michael Wood Chief Commercial Officer | SOpen-market sale Common Stock | -2,254 | $2.53 | $5,703 | 287,656 | Jun 9, 2023 |
| Jun 7, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -2,254 | $2.53 | $5,703 | 295,855 | Jun 9, 2023 |
| Jun 7, 2023 | Kevin M Sun Chief Financial Officer | SOpen-market sale Common Stock | -2,549 | $2.53 | $6,449 | 293,306 | Jun 9, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Mark Bryan AguillardChief Commercial Officer
- Ramin AkhavanGeneral Counsel
- John DobakChief Executive Officer
- Claudia IbarraChief Operating Officer
- Rtw Investments, LPdirector, owner, other
- Kevin M SunChief Financial Officer
- Todd Michael WoodChief Commercial Officer
Questions about DMTK
Answered from the filings on this page, as of the latest one.
Are insiders buying DMTK?
No. In the last 90 days no insider at DermTech, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade DMTK on the open market?
Ramin Akhavan (General Counsel) sold $5,765 of DMTK on Dec 7, 2023 and filed the Form 4 on Dec 11, 2023. InsiderTell scored 30 (weak), with 3 insiders on the same side within 14 days.
How many insiders file Form 4 at DermTech, Inc.?
7 people have filed a Form 4 at DermTech, Inc., among them Mark Bryan Aguillard (Chief Commercial Officer), Ramin Akhavan (General Counsel), John Dobak (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.